Company profile
Pharmadrug Inc.
OTC: LMLLF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Toronto, ONReports USD
#1166 of 1,422 Healthcare companies by revenue
EA Score
——FH 24DQ —GM —SS 34
v0.1 · 35/100 weight · pillars only
↑ disclosure history, listing tenure · ↓ balance-sheet leverage, Altman-Z
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$274.0k
Employees
9
as of 2026-08-26
Market cap
$805.3k
as of 2026-08-26
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$00 CAD2025
Net income-$274.0k-383.1k CAD2025
Operating income-$161.5k-225.7k CAD2025
Total assets$402.2k551.2k CAD2025
Liabilities$1.6M2.2M CAD2025
Equity-$1.3M-1.8M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Pharmadrug Inc.’s revenue?
Pharmadrug Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Odyssey Health, Inc.21DAvalon GloboCare Corp.35DGenix Pharmaceuticals Corporation——Agentix Corp.17DNKGen Biotech, Inc.——ChitogenX Inc.——Key facts
CEODavid Kideckel
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersToronto, ON
ExchangeOTC: LMLLF
Employees9
IPO date2017-05-19
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.